In regard to correlation between MET expression and outcome in patients with bladder cancer, several reports have indicated that MET levels do correlate with the progression and several studies have shown that its overexpression is associated with shortened metastasis-free and overall survival in patients with bladder cancer [68,77,78]. The gene discussed is MET; the disease is urinary bladder carcinoma.